Accessibility Menu
Singular Health Group logo

Singular Health Group(ASX) SHG

Market CapA$59.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-50%
5 Year-30%
1 Year-43%
1 Month-14%
A$0.19
-2.63%
-0.01Today
Singular Health Group last closing stock price
MetricPriceDate
Last closeAUD 0.192026-08-13
Singular Health Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.63%AUD 0.192026-08-06
1 month-13.95%AUD 0.222026-07-14
3 month-17.78%AUD 0.232026-05-15
Year to date-27.45%AUD 0.262025-12-31
1 year-43.08%AUD 0.332025-08-13
3 year+374.36%AUD 0.042023-08-10
5 year-29.52%AUD 0.262021-08-13
Since inception-50%AUD 0.382021-02-12

Singular Health Group Financials at a Glance

Market Cap

A$59.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$1.84M

Net Income (TTM)

-A$13.13M

EPS (TTM)

-A$0.02

P/E Ratio

-7.58

Dividend

A$0.00

Beta (Volatility)

0.14 (Low)

Price

A$0.19

Volume

0

Open

A$0.19

Previous Close

A$0.19

Daily Range

A$0.19 - A$0.19

52-Week Range

A$0.17 - A$0.36

Estimated Earnings Date

N/A

SHG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Singular Health Group

Singular Health Group Ltd is a medical technology company focused on developing and commercializing a volumetric rendering platform (VRP). This innovative platform enables three-dimensional and virtual reality presentations of anatomical data derived from standard radiological imaging.

Products and Services
  • 3Dicom Viewer for interactive 2D medical image engagement
  • 3DicomVSP for comprehensive surgical planning
  • Health Academy, a multi-language educational platform
Growth Outlook
  • Strong demand for VR technology in healthcare is expected to drive growth
  • Expansion into educational sectors enhances market reach
  • Partnerships with healthcare providers may boost product adoption
Financial Highlights
  • Recent quarterly revenue of AUD 479,295 shows potential for growth
  • Cash and short-term investments total AUD 11,057,133, providing liquidity
  • Current ratio of 15.98 indicates strong short-term financial health
Singular Health Group Ltd operates in the healthcare information services industry, leveraging advanced technology to enhance medical imaging and education. The company's flagship products, including the 3Dicom Viewer and 3DicomVSP, are designed to improve surgical planning and patient engagement. With a focus on innovation, the company is well-positioned to capitalize on the growing demand for virtual reality applications in healthcare. The growth outlook remains promising, driven by increasing interest in VR technology and potential partnerships with healthcare providers. Financially, the company has demonstrated resilience, with a solid cash position and a favorable current ratio, indicating the ability to meet short-term obligations. As the healthcare sector continues to evolve, Singular Health Group Ltd is poised to play a significant role in shaping the future of medical imaging and education.
AI Generated • Jul 30, 2026

Industry

Health Care Technology

Sector

Health Care

CEO

Denning Chong

Website

www.singular.health

Headquarters

Leederville, WA 6007, AU

SHG Financials

Key Financial Metrics (TTM)

Gross Margin

-208.84%

Operating Margin

-809.00%

Net Income Margin

-772.78%

Return on Equity

-59.96%

Return on Capital

-47.33%

Return on Assets

-59.23%

Earnings Yield

-13.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$59.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

324.27M

Volume

0

Avg. Volume

375.09K

Financials (TTM)

Gross Profit

-A$1.69M

Operating Income

-A$10.97M

EBITDA

-A$12.73M

Operating Cash Flow

-A$7.45M

Capital Expenditure

-A$153.98K

Free Cash Flow

-A$7.60M

Cash & ST Invst.

A$11.06M

Total Debt

A$113.71K

Singular Health Group Performance Analysis

Singular Health Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 54,034N/A
20232023-06-30AUD 28,122-48.0%
20242024-06-30AUD 90,825223.0%
20252025-06-30AUD 203,069123.6%
Singular Health Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30510.3%
Q22024-12-30-90.6%
Q42025-06-30539.8%
Q22025-12-31-0.6%
Singular Health Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.06N/A
20232023-06-30AUD -0.05-15.8%
20242024-06-30AUD -0.03-37.1%
20252025-06-30AUD -0.03-12.0%
Singular Health Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-96.6%
Q22024-12-30-5.3%
Q42025-06-30-15.0%
Q22025-12-3130.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$479.30K

+264.5%

Gross Profit

-A$2.20M

-2750.7%

Gross Margin

-4.58%

N/A

Market Cap

A$59.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$7.50M

N/A

Employees

8

N/A

Net Income

-A$2.97M

-161.4%

EBITDA

-A$3.64M

-284.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$11.06M

+33997.5%

Total Debt

A$113.71K

-91.8%

Accounts Receivable

A$929.35K

+34.1%

Inventory

A$0.00

-100.0%

Long Term Debt

A$93.87K

-55.4%

Short Term Debt

A$19.85K

-98.3%

Return on Assets

-59.23%

N/A

Return on Invested Capital

-66.02%

N/A

Free Cash Flow

-A$3.23M

-536.2%

Operating Cash Flow

-A$3.11M

-601.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CYC.AXCyclopharm Limited
A$0.52-2.80%
M7T.AXMach7 Technologies Limited
A$0.28+0.00%
MVP.AXMedical Developments International Limited
A$0.46-4.17%
ATX.AXAmplia Therapeutics Limited
A$0.15+3.57%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.56+0.02%
CDECoeur Mining
$18.45-0.02%
TAT&T
$24.58+0.01%
SMRNuScale Power
$9.85+0.03%

Questions About SHG

What is the current price of Singular Health Group?

Singular Health Group is trading at A$0.19 per share.

What is the 52-week range for Singular Health Group?

Over the past 52 weeks, Singular Health Group has traded between A$0.17 and A$0.36.

How much debt does Singular Health Group have?

As of the most recent reporting period, Singular Health Group reported total debt of A$0.00.

How much cash does Singular Health Group have on hand?

Singular Health Group reported A$13.68M in cash and cash equivalents in its most recent financial results.

What is Singular Health Group’s dividend yield?

Singular Health Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services